Clinical Trial Update: RESET Trial - Part 1 - A Phase 3 Trial in Subjects With Sjögren-Larsson Syndrome (SLS) [Phase 3]

View source ↗

Summary

Phase 3 trial update for Sjögren-Larsson Syndrome (RESET Trial Part 1) completed with results posted in 2023.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sjögren-larsson Syndrome

Drugs mentioned

• Aldeyra Therapeutics product used in RESET Trial

Snippet

Sponsor: Aldeyra Therapeutics, Inc. | Conditions: Sjogren-Larsson Syndrome | Phase 3 | Status: COMPLETED | Results posted: 2023-02-09